Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Flexion Therapeutics, Inc. (FLXN)

« Back to company index

FLXN Chatter Timeline

Stock Ticker for FLXN

Most Active Tweeters for FLXN

UserTweets
@Tickeron 6
@bio_report 4
@otcdynamics 3
@stock_titan 3
@kevinjaybe 3

Recent Tweets for FLXN

newsfilterio @newsfilterio
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 $FLXN https://t.co/MCemHGDNgD
May 7th 2021, 10:05pm
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/uzxckdKAzP
May 7th 2021, 8:05pm
kevinjaybe @kevinjaybe
$FLXN Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://t.co/IEALUWXo5I
May 7th 2021, 8:05pm
stock_titan @stock_titan
$FLXN Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/FmhuqrfKk6
May 7th 2021, 8:05pm
Tickeron @Tickeron
$FLXN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/F8XThabKWB
May 7th 2021, 1:05am
bio_report @bio_report
$FLXN lots of money to be made here. Punished with biotech in general despite huge revenue growth forecast this year.
May 6th 2021, 7:05pm
newsfilterio @newsfilterio
Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021 $FLXN https://t.co/cwEtl7jGB1
May 6th 2021, 4:05am
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021 https://t.co/y3kWcXAfo7
May 5th 2021, 8:05pm
kevinjaybe @kevinjaybe
$FLXN Flexion Therapeutics To Report First-Quarter 2021 Financial Results On May 12, 2021 https://t.co/euIWo5K9tC
May 5th 2021, 8:05pm
stock_titan @stock_titan
$FLXN Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021 https://t.co/xCz48gI38b
May 5th 2021, 8:05pm
Tickeron @Tickeron
$FLXN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/u6BTkiM2Je
May 5th 2021, 4:05pm
EZMoney_41 @EZMoney_41
$FLXN Now awaiting Buy signal... https://t.co/1hB5hRptsX
May 5th 2021, 2:05am
StckPro @StckPro
$FLXN NEW ARTICLE : It's Time To Buy Flexion Therapeutics As Revenue Is Expected To Grow https://t.co/CetZOjve2m Ge… https://t.co/E69IvvaBhP
May 4th 2021, 9:05pm
SeekingAlpha @SeekingAlpha
$FLXN - It's Time To Buy Flexion Therapeutics As Revenue Is Expected To Grow. https://t.co/eyvjAFss8w #finance #economy #business
May 4th 2021, 9:05pm
bio_report @bio_report
$FLXN all logic is now out the window on today’s drop. Guiding 50% revenue growth this year and only trading at 3X multiple.
May 4th 2021, 5:05pm
ChartMill @ChartMill
Based on estimates for the next 2 years, $FLXN will show a very strong growth in EPS: 44.56% on average per year.… https://t.co/LyQaJj37EP
May 4th 2021, 3:05am
KillerStockCall @KillerStockCall
Expected Biotech News $FLXN FX201 Phase 1 Presentation 11 May 21 $SIOX AXO-AAV-GM1 Phase 1/2 Presentation 13 May 2… https://t.co/qTKFG3qtom
May 2nd 2021, 4:05pm
Tickeron @Tickeron
$FLXN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/iUnLRHgUOm
May 2nd 2021, 6:05am
kwhenfinance @kwhenfinance
Flexion Therapeutics Inc Shares Close in on 52-Week Low - Market Mover https://t.co/gOFJAVoElg $FLXN #stockmarket #kwhenfinance
May 1st 2021, 3:05pm
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on April 21, 2021. View odds for this and other indicators:… https://t.co/WVdZAa8qaR
April 30th 2021, 7:04pm
SwingTradeBot @SwingTradeBot
New 52 Week Low today: $FLXN ... https://t.co/0EM4q8YtyQ
April 30th 2021, 6:04pm
bio_report @bio_report
$FLXN only trades at 3X revenue guidance. Lower than even big pharma like $GILD. Emerging biotech in hyper growth m… https://t.co/Gw4hsgz0U8
April 29th 2021, 3:04pm
StockTexts @StockTexts
$FLXN Flexion Therapeutics, Inc. SEC Filing: Form DEFA14A https://t.co/FGUZY3WKOz
April 29th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$FLXN [15s. delayed] filed form DEFA14A on April 29, 07:30:24 https://t.co/BDu9DhArqN
April 29th 2021, 11:04am
StockTexts @StockTexts
$FLXN Flexion Therapeutics, Inc. SEC Filing: Form DEF 14A https://t.co/npy9YdcvMq
April 29th 2021, 11:04am
fintel_io @fintel_io
$FLXN / Flexion Therapeutics files form DEF 14A https://t.co/DKxGDghVGo
April 29th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$FLXN [15s. delayed] filed form DEF 14A on April 29, 07:00:23 https://t.co/4GiQfOPBor
April 29th 2021, 11:04am
bio_report @bio_report
$FLXN so so undervalued
April 28th 2021, 7:04pm
SmallCapsDaily @SmallCapsDaily
$FLXN Flexion Therapeutics Announces Presentation of Preliminary FX201 Clinical Data at the Upcoming 2021 American… https://t.co/9hbZWMTvTp
April 28th 2021, 3:04pm
Briefingcom @Briefingcom
$FLXN: Flexion Therapeutics to present preliminary data from Phase 1 trial of FX201 https://t.co/Mwcj4r2SCF
April 28th 2021, 1:04pm
IOInvestors @IOInvestors
$FLXN +1.7% (to present preliminary data from Phase 1 trial of FX201) https://t.co/9MqMuXxLOQ
April 28th 2021, 12:04pm
glitchbotio @glitchbotio
RT @MarketCurrents: $FLXN - Flexion Therapeutics' FX201 shows encouraging action in knee osteoarthritis https://t.co/RctcHRDlL4
April 28th 2021, 12:04pm
MarketCurrents @MarketCurrents
$FLXN - Flexion Therapeutics' FX201 shows encouraging action in knee osteoarthritis https://t.co/RctcHRDlL4
April 28th 2021, 12:04pm
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics Announces Presentation of Preliminary FX201 Clinical Data at the Upcoming 2021 American… https://t.co/b64CdiTE4j
April 28th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$FLXN [15s. delayed]: Issued Press Release on April 28, 07:30:00: Flexion Therapeutics Announces Presentation of Pr… https://t.co/0ALZhmjhhs
April 28th 2021, 11:04am
kevinjaybe @kevinjaybe
$FLXN Flexion Therapeutics Announces Presentation Of Preliminary Fx201 Clinical Data At The Upcoming 2021 American… https://t.co/veGCLsWMl1
April 28th 2021, 11:04am
stock_titan @stock_titan
$FLXN Flexion Therapeutics Announces Presentation of Preliminary FX201 Clinical Data at the Upcoming 2021 American… https://t.co/d5yu6lQMHf
April 28th 2021, 11:04am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on April 21, 2021. View odds for this and other indicators:… https://t.co/gxajxGtMDg
April 28th 2021, 6:04am
SentiQuanti @SentiQuanti
Random Main Losers on 2021-04-26 : $FLXN with Returns -5.23%
April 27th 2021, 9:04am
MarcJacksonLA @MarcJacksonLA
$FLXN Credit Suisse Resumed Coverage On Flexion Therapeutics With A Buy Rating, $17 PT https://t.co/XfzOqW8UQ6
April 26th 2021, 7:04pm
DaytradingArts @DaytradingArts
$FLXN broke intraday flag - hod - looks good
April 26th 2021, 5:04pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $FLXN - Amount: $2,082,360.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
April 26th 2021, 3:04pm
sbwcws @sbwcws
Flexion assumed with an Outperform at Credit Suisse $FLXN
April 26th 2021, 10:04am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on April 21, 2021. View odds for this and other indicators:… https://t.co/3YYVfOCq0E
April 26th 2021, 7:04am
BetulaKapital @BetulaKapital
Flexion Therapeutics (@FlexionInc) $FLXN Kort summering: https://t.co/fFt9A2AO1d
April 25th 2021, 3:04pm
mediasentiment @mediasentiment
$FLXN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 64
April 24th 2021, 9:04am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on April 21, 2021. View odds for this and other indicators:… https://t.co/ZJK2GIqHls
April 24th 2021, 6:04am
bio_report @bio_report
$FLXN any other biotech guiding 50% revenue growth on $100M+ and trading under a billion market cap?
April 23rd 2021, 2:04pm
daviddoughty @daviddoughty
RT @WilliamThrow20: $FLXN Look at the consistent revenue growth on this thing. Trading at historic support levels.… https://t.co/jnFkcOLXIa
April 23rd 2021, 7:04am
WilliamThrow20 @WilliamThrow20
$FLXN Look at the consistent revenue growth on this thing. Trading at historic support levels. Excellent analyst… https://t.co/QgJY7cJOjX
April 23rd 2021, 6:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.